Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid­-Conjugate Vaccine (MenACYW­-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study

Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid­-Conjugate Vaccine (MenACYW­-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study

Relevance. Invasive meningococcal disease (IMD) has high morbidity and mortality, with infants and young children among those at greatest risk.Materials & Methods. A phase III, open-­label, randomized study in toddlers aged 12–23 months evaluated the immunogenicity and safety of MenACYW­TT,...

Full description

Bibliographic Details
Main Authors: L. S. Namazova­-Baranova, O. A. Perminova, T. A. Romanova, V. V. Romanenko, A. N. Galustyan, V. N. Gorodin, I. V. Osipova, V. Yu. Rodnikova, S. M. Kharit, Yu. V. Kovshirina, V. А. Anokhin, S. B’Chir, D. Neveu, M. Bonaparte, G. Áñez, E. Jordanov, M. S. Dhingra, A. V. Goldstein
Format: Article
Language:Russian
Published: Numikom LLC 2023-01-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
вакцина
менигококк menacyw­-tt
одновременная вакцинация
pcv13
иммуногенность
безопасность
Online Access:https://www.epidemvac.ru/jour/article/view/1706

Internet

https://www.epidemvac.ru/jour/article/view/1706

Similar Items